BSE filing, NSE: CITURGIBIO. Summary written from the filing by ALFA Finder's alert engine.
Citurgia Biochemicals Ltd: key numbers
- Share price
- ₹102.45
- Market cap
- ₹1,353 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.74 Cr
- P/E (TTM)
- -1827.2×Sector 34.1×
- Promoter holding
- 99.36%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Citurgia Biochemicals Ltd
All →Citurgia Biochemicals Board Meeting Date
Citurgia Biochemicals Limited has scheduled its board meeting for November 14, 2026. The meeting will consider and approve unaudited financial results for the quarter ended September 2026.
Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Ltd has submitted its quarterly shareholding pattern disclosure as required under Regulation 31(1)(b) of the SEBI Listing Regulations.
Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Ltd submitted its Regulation 74(5) compliance certificate from the RTA for the quarter ended September 30, 2026. This is a standard regulatory disclosure.
Citurgia Biochemicals Board Meeting Date
Citurgia Biochemicals announced a board meeting on October 6, 2026, to discuss scheduling the 51st Annual General Meeting and approving associated reports.
Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Limited received approval from the Registrar of Companies for a one-month extension to hold its 51st Annual General Meeting by October 31, 2026.
Citurgia Biochemicals Management Change
Citurgia Biochemicals submitted the resignation letter of CS Yatendra Kumar, effective 24 July 2026. The filing rectifies a prior omission of the letter under Regulation 30 (LODR).
Other other announcement announcements
All →Brand Concepts Other Announcement
Brand Concepts Limited reported zero deviation in the utilization of funds raised through convertible warrants for the quarter ended September 2026. The company utilized the entire raised amount of Rs. 14.75 Crore for working capital and business expansion.
Mankind Pharma Other Announcement
Mankind Pharma Limited received an ESG rating of 64.8 from SES ESG Research. This rating was independently assigned for FY26 based on publicly available information.
Moneyview Other Announcement
Moneyview Ltd has appointed Ankit Kumar Jain as Nodal Officer for the Investor Education and Protection Fund. This role handles claim verification and coordination with the IEPF Authority.
Mastek Other Announcement
Mastek Limited has announced a change in the corporate office address of its Registrar and Share Transfer Agent, KFin Technologies Limited. The change is effective December 1, 2026.
Desi Farms India Other Announcement
Desi Farms India Ltd has appointed M/s Ojha Agrawal & Associates as Statutory Auditors. The appointment fills a casual vacancy following the resignation of the previous auditors.
Faze Three Other Announcement
Faze Three Ltd files its quarterly shareholding pattern as of 30 September 2026. The filing notes 2,78,840 shares allotted to its ESOP trust on 11 August 2026.